{"title":"Risk stratification scoring system for femoral neck bony stress injuries in military recruits: a pilot study.","authors":"Benjamin Atkin, J Evans, R Hemingway","doi":"10.1136/military-2025-003014","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bony stress injury (BSI) is an overuse injury through excessive repetitive loads on normal healthy bone that commonly affects military recruits. Confirmation of diagnosis often requires costly investigations such as MRI, and there is a need for better prior screening procedures. This study aimed to assess a clinical risk assessment tool 'Hip1' for its utility to screen and identify BSI for further detailed confirmatory investigation.</p><p><strong>Methods: </strong>A retrospective cohort study using the Defence Medical Information Capability Programme, identifying all patients potentially presenting with BSI from clinical codes between 1 January 2021 and 31 December 2022 inclusive. All records were reviewed to determine if a 'Hip1' score had been performed by either a doctor or physiotherapist, and related to further investigations (X-ray and/or MRI reports) and patient outcomes.</p><p><strong>Results: </strong>47/213 patients were eligible. In the high-risk group (n=23), the mean Hip1 score was 7.4±1.7 versus the low-risk group (n=24), with a mean Hip1 score of 3.1±0.73. Nine patients from the high-risk group had a positive diagnosis of a BSI with a mean Hip1 score of 7.7±1.7. All patients in the low-risk group had a negative diagnosis and returned to training. Comparison between positive and negative cohorts gave the Hip1 score a sensitivity of 100% (95% CI 66.4% to 100%), specificity of 63.2% (95% CI 45.9% to 78.2%), positive predictive value of 39.1% (95% CI 29.8% to 49.3%) and negative predictive value of 100% (95% CI, N/A). Patients with a score of ≥5 were more likely to have a BSI than those with a score of ≤4 (p<0.05).</p><p><strong>Conclusions: </strong>The Hip1 clinical scoring system showed high sensitivity with a very high negative predictive value to exclude those subjects that did not have a BSI; therefore, reducing unnecessary investigation, while directing the diagnostic resources to those who were most likely to require them.</p>","PeriodicalId":48485,"journal":{"name":"Bmj Military Health","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bmj Military Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/military-2025-003014","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Bony stress injury (BSI) is an overuse injury through excessive repetitive loads on normal healthy bone that commonly affects military recruits. Confirmation of diagnosis often requires costly investigations such as MRI, and there is a need for better prior screening procedures. This study aimed to assess a clinical risk assessment tool 'Hip1' for its utility to screen and identify BSI for further detailed confirmatory investigation.
Methods: A retrospective cohort study using the Defence Medical Information Capability Programme, identifying all patients potentially presenting with BSI from clinical codes between 1 January 2021 and 31 December 2022 inclusive. All records were reviewed to determine if a 'Hip1' score had been performed by either a doctor or physiotherapist, and related to further investigations (X-ray and/or MRI reports) and patient outcomes.
Results: 47/213 patients were eligible. In the high-risk group (n=23), the mean Hip1 score was 7.4±1.7 versus the low-risk group (n=24), with a mean Hip1 score of 3.1±0.73. Nine patients from the high-risk group had a positive diagnosis of a BSI with a mean Hip1 score of 7.7±1.7. All patients in the low-risk group had a negative diagnosis and returned to training. Comparison between positive and negative cohorts gave the Hip1 score a sensitivity of 100% (95% CI 66.4% to 100%), specificity of 63.2% (95% CI 45.9% to 78.2%), positive predictive value of 39.1% (95% CI 29.8% to 49.3%) and negative predictive value of 100% (95% CI, N/A). Patients with a score of ≥5 were more likely to have a BSI than those with a score of ≤4 (p<0.05).
Conclusions: The Hip1 clinical scoring system showed high sensitivity with a very high negative predictive value to exclude those subjects that did not have a BSI; therefore, reducing unnecessary investigation, while directing the diagnostic resources to those who were most likely to require them.
背景:骨应激性损伤(BSI)是一种通过对正常健康骨骼的过度重复性负荷而造成的过度使用性损伤,通常影响新兵。确诊通常需要昂贵的检查,如核磁共振成像,并且需要更好的预先筛查程序。本研究旨在评估临床风险评估工具“Hip1”在筛查和识别BSI方面的效用,以进行进一步详细的确证性调查。方法:采用国防医疗信息能力计划进行回顾性队列研究,确定2021年1月1日至2022年12月31日期间临床代码中所有可能出现BSI的患者。查看所有记录,以确定医生或物理治疗师是否进行了“Hip1”评分,并与进一步的调查(x射线和/或MRI报告)和患者结果有关。结果:47/213例患者符合条件。高危组(n=23)平均Hip1评分为7.4±1.7,低危组(n=24)平均Hip1评分为3.1±0.73。高危组9例BSI阳性诊断,平均Hip1评分为7.7±1.7。低危组的所有患者诊断结果均为阴性,并恢复训练。阳性和阴性队列的比较显示,Hip1评分的敏感性为100% (95% CI 66.4%至100%),特异性为63.2% (95% CI 45.9%至78.2%),阳性预测值为39.1% (95% CI 29.8%至49.3%),阴性预测值为100% (95% CI, N/ a)。评分≥5分的患者发生BSI的可能性高于评分≤4分的患者(p结论:Hip1临床评分系统对排除无BSI的患者具有很高的敏感性和非常高的阴性预测值;因此,减少不必要的调查,同时将诊断资源导向那些最有可能需要它们的人。